Clinical Trial Update: Chondromodulating Effect of Diacerein in Osteoarthritis of the Hip [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the chondromodulating effect of diacerein in hip osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Diacerein (Diacerein)

Snippet

Sponsor: Laboratoires NEGMA | Conditions: Hip Osteoarthritis | Phase 3 | Status: COMPLETED